Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026
Go back to Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.67 +0.17 (3.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.50 | 52 Week High | $45.34 | |||
| Open | $4.41 | 52 Week Low | $15.92 | |||
| Day High | $4.71 | P/E | 2.00 | |||
| Day Low | $4.39 | EPS | $2.33 | |||
| Volume | 511,647 | |||||
